BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from โ10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
BGSF
BGSF, Inc.
There isn't enough reported data to score BGSF yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
BGSF Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Unavailable | |
| Weak |
BGSF's revenue, profitability and balance sheet are currently under pressure. There isn't enough data to rate its cash flow.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | โ |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
BGSF PE Valuation
BGSF has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
BGSF Forward outlook
There aren't enough analyst estimates for BGSF to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over BGSF in the latest year-over-year earnings comparison.
BGSF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.19 | +$0.84 |
BGSF is still losing money, but far less than before: $0.19 per share over the past year, against $1.03 at its worst in late 2025.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over BGSF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over BGSF on profitability, with a higher operating margin.
BGSF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.1M | -6.6% |
| Q2 2026 | $22.3M | -5.1% |
| Q1 2026 | $20.9M | -67% |
| Q4 2025 | $22M | -66% |
| Q3 2025 | $26.9M | +37681% |
| Q2 2025 | $23.5M | +34398% |
| Q4 2024 | $64.4M | -12% |
| Q4 2023 | $73.6M | -4.8% |
BGSF's revenue has slid since its 2021 peak: $25M last quarter, down 6.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.8% | N/A |
| Q2 2026 | -5.3% | +14 points |
| Q1 2026 | -7.4% | N/A |
| Q4 2025 | -8% | -9.9 points |
| Q2 2025 | -19% | -19 points |
| Q4 2024 | 1.9% | +12 points |
| Q3 2024 | 0.7% | N/A |
| Q2 2024 | 0.1% | N/A |
BGSF's operating margin was 0.8% last quarter, up 20 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BGSF has the stronger cash trend. Its trailing FCF is up 140% versus its history, compared with BA at up 100%.
BGSF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $1.7M | -93% |
| Q4 2024 | $22.7M | +28% |
| Q4 2023 | $17.8M | +$18.1M |
| Q4 2022 | -$291.8K | -111% |
| Q3 2022 | -$7.9M | -5272% |
| Q2 2022 | -$2.2M | -$1.4M |
| Q1 2022 | -$2.4M | -279% |
| Q4 2021 | $2.7M | -29% |
BGSF usually generates cash, though not every quarter: the latest was โ$343,000, but it generated $24M over the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
BGSF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | 4.0x | High |
| Q3 2024 | 0.0x | Very low |
| Q4 2022 | 2.0x | Healthy |
| Q3 2022 | 0.0x | Very low |
| Q2 2022 | -0.0x | Very low |
| Q1 2022 | 0.0x | Very low |
| Q4 2021 | 1.5x | Healthy |
| Q3 2021 | 1.5x | Healthy |
BGSF's net debt is about 4.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
BGSF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.3 | Neutral |
| Stochastic | 15.1 | Oversold |
BGSF's weekly RSI is 31 (neutral) and its Stochastic is 15 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
BGSF PE vs Industrials Sector
| Metric | BGSF | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | โ |
BGSF has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
BGSF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.37 | 13% below |
| 20 week MA | $5.04 | 24% below |
| 50 week MA | $5.35 | 29% below |
| 100 week MA | $5.13 | 26% below |
| 200 week MA | $7.28 | 48% below |
BGSF is in a downtrend: it's below all five of its weekly moving averages, and 48% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
BGSF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.2 | $12.6 | -40% |
| 2021 | $12.6 | $14.0 | +11% |
| 2022 | $14.0 | $15.0 | +7.1% |
| 2023 | $15.0 | $9.40 | -37% |
| 2024 | $9.40 | $6.14 | -35% |
| 2025 | $6.14 | $4.76 | -22% |
| 2026 YTD | $4.76 | $3.82 | -20% |
BGSF has the edge over BA on returns for 2026, with the stronger performance.